Shanghai - Delayed Quote CNY

Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS)

47.63 +2.64 (+5.87%)
At close: April 26 at 3:00 PM GMT+8
Key Events
Loading Chart for 688799.SS
DELL
  • Previous Close 44.99
  • Open 45.24
  • Bid 47.63 x --
  • Ask 47.64 x --
  • Day's Range 44.82 - 48.33
  • 52 Week Range 30.02 - 52.97
  • Volume 1,913,046
  • Avg. Volume 1,281,589
  • Market Cap (intraday) 4.468B
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 20.18
  • EPS (TTM) 2.36
  • Earnings Date --
  • Forward Dividend & Yield 0.90 (1.89%)
  • Ex-Dividend Date Oct 19, 2023
  • 1y Target Est --

Hunan Warrant Pharmaceutical Co.,Ltd manufactures and sells pharmaceutical products. It offers medicines in the areas of digestive, berating, anti-infection, gynecology, cardiovascular, cerebrovascular, immunology and nephrology, and other fields. Hunan Warrant Pharmaceutical Co.,Ltd was founded in 2001 and is based in Changsha, China.

www.warrant.com.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 688799.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

688799.SS
2.68%
SSE Composite Index
3.82%

1-Year Return

688799.SS
25.49%
SSE Composite Index
5.40%

3-Year Return

688799.SS
--
SSE Composite Index
13.40%

5-Year Return

688799.SS
--
SSE Composite Index
13.40%

Compare To: 688799.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688799.SS

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    4.47B

  • Enterprise Value

    4.05B

  • Trailing P/E

    20.18

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.10

  • Price/Book (mrq)

    2.50

  • Enterprise Value/Revenue

    2.80

  • Enterprise Value/EBITDA

    16.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.38%

  • Return on Assets (ttm)

    7.18%

  • Return on Equity (ttm)

    12.45%

  • Revenue (ttm)

    1.44B

  • Net Income Avi to Common (ttm)

    222.16M

  • Diluted EPS (ttm)

    2.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    461.51M

  • Total Debt/Equity (mrq)

    2.58%

  • Levered Free Cash Flow (ttm)

    -37.94M

Company Insights: 688799.SS

People Also Watch